Welcome to our dedicated page for Universal Health news (Ticker: UHT), a resource for investors and traders seeking the latest updates and insights on Universal Health stock.
Universal Health Realty) Trust (UHT) provides investors with centralized access to official announcements and market developments for this healthcare-focused REIT. This page aggregates all material disclosures including earnings reports, property acquisitions, and strategic partnerships essential for understanding UHT's position in medical real estate markets.
Users will find press releases, regulatory filings, and operational updates related to UHT's portfolio of healthcare facilities. Content spans lease agreements, advisory service expansions, and financial performance metrics while adhering to factual reporting standards.
This resource enables efficient tracking of UHT's activities in acute care hospitals, outpatient centers, and medical office buildings. The Trust's unique position at the intersection of healthcare services and real estate investment is reflected through curated news highlighting tenant relationships and portfolio diversification.
Bookmark this page for streamlined monitoring of UHT's developments in a sector requiring specialized property management expertise. Cross-reference announcements with SEC filings and industry analysis for informed decision-making.
Universal Health Realty Income Trust reported its Q1 2025 financial results, showing a decline in performance compared to Q1 2024. Net income decreased to $4.8 million ($0.34 per diluted share) from $5.3 million ($0.38 per diluted share) in the previous year.
The decline was attributed to:
- A $401,000 decrease from lower income at various properties
- A $122,000 increase in interest expense due to higher borrowings and rates
Key financial highlights:
- FFO (Funds From Operations) reached $11.9 million ($0.86 per share)
- Quarterly dividend of $0.735 per share paid on March 31, 2025
- Available borrowing capacity of $75.5 million on $425 million credit facility
The healthcare REIT maintains investments in 76 properties across 21 states, including acute care hospitals, behavioral health facilities, and medical office buildings. Management noted concerns about interest rates, staffing challenges, and potential Medicaid funding reductions affecting future performance.
Universal Health Services (UHS) reported strong Q1 2025 financial results, with net income reaching $316.7 million ($4.80 per diluted share), up from $261.8 million in Q1 2024. Net revenues increased 6.7% to $4.1 billion.
Key performance highlights:
- Adjusted net income: $319.5 million ($4.84 per share)
- EBITDA: $603.9 million, up from $525.9 million
- Acute care facilities saw 2.4% increase in adjusted admissions
- Behavioral health facilities experienced slight decline in admissions (-1.6%)
The company's operating cash flow was $360 million, down from $396 million in Q1 2024. UHS continued its stock repurchase program, buying back 1.0 million shares for approximately $180.6 million. The company maintains strong liquidity with $1.02 billion available borrowing capacity on its revolving credit facility.
Universal Health Realty Income Trust (NYSE:UHT) has declared a dividend of $0.735 per share, payable on March 31, 2025, to shareholders of record as of March 24, 2025.
The company, operating as a real estate investment trust (REIT), specializes in healthcare and human service-related facilities investments. Their portfolio encompasses 76 properties across 21 states, including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute care facilities, surgery centers, childcare centers, and medical office buildings.
Universal Health Realty Income Trust (NYSE:UHT) reported strong financial results for Q4 and full-year 2024. Q4 net income reached $4.7 million ($0.34 per diluted share), up from $3.6 million ($0.26 per diluted share) in Q4 2023. Full-year 2024 net income was $19.2 million ($1.39 per diluted share), compared to $15.4 million in 2023.
The company's Funds from Operations (FFO) for Q4 2024 were $11.8 million ($0.85 per diluted share), increasing from $11.4 million in Q4 2023. Full-year FFO reached $47.9 million ($3.46 per diluted share), up from $44.6 million in 2023.
Notable developments include a credit agreement expansion to $425 million from $375 million, with maturity extended to September 2028. The company also entered a new interest rate swap agreement for $85 million at 3.2725% fixed rate. The Sierra Medical Plaza I in Reno, Nevada, is now 68% leased with an estimated total cost of $35 million.
Universal Health Services (UHS) reported strong financial results for Q4 and full-year 2024. Q4 net income reached $332.4 million ($4.96 per share), up from $216.4 million in Q4 2023. Q4 revenues increased 11.1% to $4.114 billion.
Full-year 2024 performance showed net income of $1.142 billion ($16.82 per share) on revenues of $15.828 billion, marking a 10.8% increase. The company's acute care facilities saw a 2.2% rise in adjusted admissions, while behavioral health facilities reported a 2.0% increase.
For 2025, UHS forecasts revenues between $17.020-17.364 billion, representing 7.5-9.7% growth. EPS is projected at $18.45-19.95, an increase of 11.1-20.1%. During 2024, UHS repurchased approximately 2.98 million shares for $598.5 million, with $824.4 million remaining in the authorization.
Universal Health Realty Income Trust (NYSE: UHT) has announced a quarterly dividend increase of $0.005, bringing the new dividend to $0.735 per share. The dividend will be paid on December 31, 2024, to shareholders of record as of December 16, 2024. The company, a real estate investment trust, maintains a portfolio of 77 healthcare and human service-related facilities across 21 states, including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, surgery centers, and medical office buildings.
Universal Health Services (UHS) reported strong financial results for Q3 2024. Net income reached $258.7 million ($3.80 per diluted share), up from $167.0 million in Q3 2023. Net revenues increased 11.2% to $3.963 billion. The company's acute care facilities saw adjusted admissions increase by 1.5%, while behavioral health facilities experienced a 2.2% rise. EBITDA margin improved to 13.3% from 11.5% year-over-year. UHS completed a $1 billion financing transaction and authorized a $1.0 billion increase to its stock repurchase program, under which it repurchased 658,000 shares for $153.9 million in Q3.
Universal Health Realty Income Trust (NYSE:UHT) reported Q3 2024 net income of $4.0 million ($0.29 per diluted share), up from $3.9 million ($0.28 per diluted share) in Q3 2023. The increase was driven by a $451,000 rise in property income, partially offset by a $326,000 increase in interest expense.
For the nine months ended September 30, 2024, net income reached $14.6 million ($1.05 per diluted share), compared to $11.8 million ($0.85 per diluted share) in 2023. The company declared a Q3 dividend of $0.73 per share. UHT also expanded its credit agreement to $425 million and extended maturity to September 2028.
Universal Health Realty Income Trust (NYSE:UHT) has announced a dividend payment of $0.73 per share, to be paid on September 30, 2024, to shareholders of record as of September 16, 2024. This decision was made by the company's Board of Trustees. UHT is a real estate investment trust that focuses on healthcare and human service-related facilities, including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute care facilities, surgery centers, childcare centers, and medical office buildings. The Trust currently has 76 investments spread across 21 states, demonstrating its diverse portfolio in the healthcare real estate sector.
Universal Health Services (NYSE: UHS) reported strong Q2 2024 financial results, with net income rising to $289.2 million ($4.26 per diluted share) compared to $171.3 million in Q2 2023. Net revenues increased by 10.1% to $3.908 billion. The company's adjusted net income was $292.6 million ($4.31 per diluted share), up from $179.4 million in Q2 2023. UHS also announced a $1 billion increase to its stock repurchase program authorization.
Based on strong performance, UHS increased its 2024 full-year forecast. Revised projections include net revenues of $15.565-$15.753 billion, adjusted EBITDA of $2.154-$2.226 billion, and adjusted EPS of $15.40-$16.20 per share. These figures represent significant increases from the original forecast, reflecting the company's positive outlook.
FAQ
What is the current stock price of Universal Health (UHT)?
What is the market cap of Universal Health (UHT)?
